SUSQUEHANNA INTERNATIONAL GROUP, LLP - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$77,509
+12.0%
56,576
+12.0%
0.00%
Q2 2023$69,188
+73.0%
50,502
+248.3%
0.00%
Q3 2022$40,000
-75.0%
14,500
-59.9%
0.00%
Q4 2021$160,000
-32.8%
36,200
+62.7%
0.00%
Q1 2021$238,00022,2470.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 1,339,793$10,598,0000.89%
CM Management, LLC 75,000$593,0000.43%
Cormorant Asset Management, LP 1,415,500$11,197,0000.38%
BVF INC/IL 1,113,435$8,807,0000.33%
Ikarian Capital, LLC 350,000$2,769,0000.22%
Woodline Partners LP 857,445$6,782,0000.13%
INGALLS & SNYDER LLC 51,149$405,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 853,208$6,749,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 40,052$317,0000.01%
Point72 Asset Management, L.P. 188,690$1,493,0000.01%
View complete list of ELEDON PHARMACEUTICALS INC shareholders